Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Concentrix (CNXC) Other Non-Current Liabilities (2020 - 2025)

Concentrix's Other Non-Current Liabilities history spans 6 years, with the latest figure at $951.0 million for Q4 2025.

  • For Q4 2025, Other Non-Current Liabilities rose 4.47% year-over-year to $951.0 million; the TTM value through Nov 2025 reached $951.0 million, up 4.47%, while the annual FY2025 figure was $951.0 million, 4.47% up from the prior year.
  • Other Non-Current Liabilities for Q4 2025 was $951.0 million at Concentrix, down from $970.6 million in the prior quarter.
  • Across five years, Other Non-Current Liabilities topped out at $970.6 million in Q2 2025 and bottomed at $468.2 million in Q3 2023.
  • The 5-year median for Other Non-Current Liabilities is $563.1 million (2021), against an average of $658.0 million.
  • The largest annual shift saw Other Non-Current Liabilities dropped 15.79% in 2022 before it surged 100.85% in 2024.
  • A 5-year view of Other Non-Current Liabilities shows it stood at $546.4 million in 2021, then decreased by 6.3% to $512.0 million in 2022, then surged by 79.79% to $920.5 million in 2023, then decreased by 1.12% to $910.3 million in 2024, then increased by 4.47% to $951.0 million in 2025.
  • Per Business Quant, the three most recent readings for CNXC's Other Non-Current Liabilities are $951.0 million (Q4 2025), $970.6 million (Q2 2025), and $910.3 million (Q4 2024).